Peer Review History
| Original SubmissionApril 8, 2025 |
|---|
|
Dear Dr. O'Connor, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Natasha Shaukat Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. In the ethics statement in the Methods, you have specified that verbal consent was obtained. Please provide additional details regarding how this consent was documented and witnessed, and state whether this was approved by the IRB 3. We noted in your submission details that a portion of your manuscript may have been presented or published elsewhere. [A preliminary version of this manuscript was uploaded to the preprint service MedRXIV.] Please clarify whether this conference proceeding or publication was peer-reviewed and formally published. If this work was previously peer-reviewed and published, in the cover letter please provide the reason that this work does not constitute dual publication and should be included in the current manuscript. 4. Thank you for stating the following financial disclosure: [This project was supported by the National Center for Advancing Translational Sciences, National Institutes of Health, through Grant KL2TR00145]. Please state what role the funders took in the study. If the funders had no role, please state: ""The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."" If this statement is not correct you must amend it as needed. Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf. 5. We notice that your supplementary file are included in the manuscript file. Please remove them and upload them with the file type 'Supporting Information'. Please ensure that each Supporting Information file has a legend listed in the manuscript after the references list. 6. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. Additional Editor Comments: Please see reviewers comments at the end. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? Reviewer #1: Yes Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes Reviewer #2: I Don't Know ********** 3. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: Yes ********** Reviewer #1: Congratulations to the authors on their well-conducted and insightful research. The authors used the Theoretical Framework of Acceptability (TFA) and the Fogg Behavior Model (FBM) to guide their data collection and analysis, which was apt. The study brings important insights into what matters most to people living with COPD. There are several notable strengths. The methodological rigor is further demonstrated through high inter-coder reliability (Krippendorff’s alpha of 0.86) and evidence of thematic saturation. The qualitative data are rich, and the authors clearly present their findings, supported by explanatory participant quotes. There are, however, a few areas where the manuscript could be improved: • The FBM mapping is not presented visually. Maybe if the authors couldinclude a figure or some form that illustrates this would help readers better understand how the model was applied. • the manuscript does not provide sufficient detail about who the caregivers are—for example, their relationship to the patient, or the intensity of their caregiving roles. A table or brief summary of this information would be useful. • The study is based in a single region and includes a sample that appears to be largely White and digitally literate. The limitations section should more clearly acknowledge how this may affect the generalisability of the findings to other populations, particularly those from more diverse or underserved backgrounds.. • It would be helpful if the authors briefly described in the Methods section how the interview guide evolved after piloting. • The manuscript mentions participant personas as separate illustrations in the supplementary materials. It would be good to clarify if these were developed solely for internal understanding or were intended for dissemination or further use. • The authors have done an excellent job of centering patient and caregiver voices in their exploration of COPD clinical research. With a few minor revisions to improve clarity and transparency, I believe this manuscript will make a valuable addition to the literature. Reviewer #2: This research explored what matters most to patients with COPD in order to better align COPD research with their real-life needs and experiences. This is a timely and interesting study. I have a few comments: 1. Did you consider the occupation of the participants? Or income? It should have a significant impact on understanding the patient’s needs/perception. 2. Can you please comment on the response rate? 3. Prior understanding/research of this topic is not well discussed. 4. In the discussion, it will be impactful to have discussions of possible barriers to addressing the patient’s needs and how to address these issues in real life. 5. Did you consider the subgroup-level analysis? (for example: by gender) 6. Did you consider key informant interviews? It can guide future implementation of research findings. Relevant articles: Sigurgeirsdottir, J., Halldorsdottir, S., Arnardottir, R. H., Gudmundsson, G., & Bjornsson, E. H. (2019). COPD patients' experiences, self-reported needs, and needs-driven strategies to cope with self-management. International journal of chronic obstructive pulmonary disease, 14, 1033–1043. https://doi.org/10.2147/COPD.S201068 Poletti, V., Bresciani, G., Banfi, P., & Volpato, E. (2024). Exploring perceptions and expectations of COPD patients: A grounded theory approach for personalized therapeutic interventions. Chronic respiratory disease, 21, 14799731241268262. https://doi.org/10.1177/14799731241268262 ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: Yes: Dr. Adrija Roy Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org |
| Revision 1 |
|
“A Good Day Is Just Being Able to Breathe": Aligning COPD Research with Patient Needs, a Qualitative Study PONE-D-25-18562R1 Dear Dr. Connor , We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support . If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Natasha Shaukat Academic Editor PLOS ONE Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #1: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #1: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes ********** Reviewer #1: Thank you for addressing all the comments. The manuscript is now okay for publication from my end. Accepted. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: Yes: Adrija Roy ********** |
| Formally Accepted |
|
PONE-D-25-18562R1 PLOS ONE Dear Dr. O'Connor, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Natasha Shaukat Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .